3-Hydroxy-10\'-apo-b,y-carotenal



Compound IDCDAMM01296
Common name3-Hydroxy-10\'-apo-b,y-carotenal
IUPAC name15-(4-hydroxy-2,6,6-trimethylcyclohexen-1-yl)-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal
Molecular formulaC27H36O2

Experimental data

Retention time14.75
Adduct[M+H]+
Actual mz393.278
Theoretical mz393.279
Error2.23
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9794

Identifiers and class information

Inchi keyHQPQTQQUHPFUOA-JNOJMRGUNA-N
SmilesO=CC=CC(=CC=CC=C(C=CC=C(C=CC1=C(C)CC(O)CC1(C)C)C)C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)392.58
Computed dipole moment(dipole)4.085
Total solvent accessible surface area (SASA)850.895
Hydrophobic component of SASA (FOSA)598.775
Hydrophilic component of SASA (FISA)134.017
Pie component of the SASA (PISA)118.103
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1511.22
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)3.7
Free energy of solvation of dipole (dip^2/V)0.0110398
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0043484
Globularity descriptor (glob)0.748469
Predicted polarizability in cubic angstroms (QPpolrz)45.179
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.633
Predicted octanol/gas partition coefficient (QPlogPoct)17.766
Predicted water/gas partition coefficient (QPlogPw)5.061
Predicted octanol/water partition coefficient (QPlogPo/w)6.456
Predicted aqueous solubility (QPlogS)-7.833
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.82
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.165
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)530.906
Predicted brain/blood partition coefficient (QPlogBB)-1.996
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)249.532
Predicted skin permeability, log Kp (QPlogKp)-2.037
PM3 calculated ionization potential (IP(ev))8.369
PM3 calculated electron affinity (EA(eV))1.242
Number of likely metabolic reactions (#metab)6
Prediction of binding to human serum albumin (QPlogKhsa)1.34
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)60.869
Number of nitrogen and oxygen atoms (#NandO)2
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P10276RARARetinoic acid receptor alphaT94085SEA
O43174CYP26A1Cytochrome P450 26A1T84634SEA
P02753RBP4Plasma retinol-binding proteinT55703SEA
P28702RXRBRetinoid X receptor betaT60077SEA
P13631RARGRetinoic acid receptor gammaT82146SEA
P48443RXRGRetinoid X receptor gammaT46456SEA
P10826RARBRetinoic acid receptor betaT61657SEA
Q92753RORBNuclear receptor ROR-betaT48812SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T94085DI0025Alzheimer disease[ICD-11: 8A20]P10276RARA
T94085DI0251Mature T-cell lymphoma[ICD-11: 2A90]P10276RARA
T84634DI0314Oesophagitis[ICD-11: DA24]O43174CYP26A1
T55703DI0212Inherited retinal dystrophy[ICD-11: 9B70]P02753RBP4
T60077DI0225Kaposi sarcoma[ICD-11: 2B57]P28702RXRB
T82146DI0005Acne vulgaris[ICD-11: ED80]P13631RARG
T82146DI0012Acute myeloid leukaemia[ICD-11: 2A60]P13631RARG
T82146DI0225Kaposi sarcoma[ICD-11: 2B57]P13631RARG
T82146DI0277Muscle calcification/ossification[ICD-11: FB31]P13631RARG
T82146DI0351Psoriasis[ICD-11: EA90]P13631RARG
T46456DI0225Kaposi sarcoma[ICD-11: 2B57]P48443RXRG
T46456DI0232Light sensitivity impairment[ICD-11: 9D45]P48443RXRG
T61657DI0225Kaposi sarcoma[ICD-11: 2B57]P10826RARB

Copyright © 2025